Literature DB >> 7678995

Soluble stem cell factor in human serum.

K E Langley1, L G Bennett, J Wypych, S A Yancik, X D Liu, K R Westcott, D G Chang, K A Smith, K M Zsebo.   

Abstract

Stem cell factor (SCF) is a recently described factor active in the early stages of hematopoiesis. It can exist in membrane-bound form and in proteolytically released soluble form. The levels and nature of SCF in human serum are described. As determined by an enzyme-linked immunosorbent assay performed for 257 samples, SCF level in serum averaged 3.3 +/- 1.1 ng/mL. The serum SCF was partially purified by immunoaffinity chromatography and analyzed by glycosidase treatments in conjunction with sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting. The results show that the SCF has N-linked and O-linked carbohydrate and corresponds to the soluble form, at or about 165 amino acids in length. The findings suggest functional importance for soluble SCF in humans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678995

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy.

Authors:  T A Fehniger; E M Bluman; M M Porter; E Mrózek; M A Cooper; J B VanDeusen; S R Frankel; W Stock; M A Caligiuri
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit.

Authors:  L Landuzzi; C De Giovanni; G Nicoletti; I Rossi; C Ricci; A Astolfi; L Scopece; K Scotlandi; M Serra; G P Bagnara; P Nanni; P L Lollini
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  Stable response after administration of stem cell factor combined with granulocyte colony-stimulating factor in aplastic anemia.

Authors:  Kensuke Usuki; Seiko Iki; Shunya Arai; Kimiko Iijima; Fumimaro Takaku; Akio Urabe
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

4.  Intranasal sirna targeting c-kit reduces airway inflammation in experimental allergic asthma.

Authors:  Wei Wu; Hui Chen; Ya-Ming Li; Sheng-Yu Wang; Xin Diao; Kai-Ge Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 5.  A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase.

Authors:  Zhi-Chao Feng; Matthew Riopel; Alex Popell; Rennian Wang
Journal:  Diabetologia       Date:  2015-02-03       Impact factor: 10.122

6.  Significance of stem cell factor and soluble KIT in patients with systemic lupus erythematosus.

Authors:  T Kitoh; H Ishikawa; S Sawada; K Koshino; Y Tokano; H Hashimoto; S Nakagawa
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

7.  Bruton's tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis.

Authors:  Melanie C Dispenza; Rebecca A Krier-Burris; Krishan D Chhiba; Bradley J Undem; Piper A Robida; Bruce S Bochner
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

8.  Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls.

Authors:  S C Bischoff; S Schwengberg; K Wordelmann; A Weimann; R Raab; M P Manns
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

9.  The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2.

Authors:  W E Carson; S Haldar; R A Baiocchi; C M Croce; M A Caligiuri
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

10.  Stem cell factor and its soluble receptor (c-kit) in serum of asthmatic patients- correlation with disease severity.

Authors:  Joanna S Makowska; Malgorzata Cieslak; Marek L Kowalski
Journal:  BMC Pulm Med       Date:  2009-06-01       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.